November 21, 2025 · Form 4 insider transaction
Paranjape Ketan bought 43,348 shares of SYRA HEALTH CORP at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan. 1/3 of the options vest on December 31, 2025 and the remainder vest in equal amounts on each of December 31, 2026 and 2027.